Hongjiang Xu

972 total citations
41 papers, 773 citations indexed

About

Hongjiang Xu is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hongjiang Xu has authored 41 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hongjiang Xu's work include Peptidase Inhibition and Analysis (6 papers), Diabetes Treatment and Management (6 papers) and Cancer therapeutics and mechanisms (5 papers). Hongjiang Xu is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Diabetes Treatment and Management (6 papers) and Cancer therapeutics and mechanisms (5 papers). Hongjiang Xu collaborates with scholars based in China, Sudan and Czechia. Hongjiang Xu's co-authors include Jun Feng, Yanan Li, Jun Xu, Jie Ma, Hongmei Gu, Xiquan Zhang, Ling‐Dong Kong, Yan‐Zi Yang, Jiu Wang and Ying Pan and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Hongjiang Xu

40 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjiang Xu China 15 373 192 124 106 89 41 773
Francesco Merlino Italy 21 508 1.4× 88 0.5× 292 2.4× 82 0.8× 72 0.8× 54 909
Yang Wan China 18 544 1.5× 160 0.8× 148 1.2× 186 1.8× 26 0.3× 73 1.2k
Othman Al Musaimi United Kingdom 18 790 2.1× 282 1.5× 144 1.2× 91 0.9× 31 0.3× 47 1.1k
Linlin Chang China 17 606 1.6× 77 0.4× 178 1.4× 134 1.3× 15 0.2× 48 1.0k
Seema Kumari India 16 708 1.9× 87 0.5× 35 0.3× 169 1.6× 15 0.2× 45 1.3k
Franklin W. Okumu United States 9 317 0.8× 49 0.3× 43 0.3× 118 1.1× 19 0.2× 12 644
Christina Lamers Germany 16 494 1.3× 175 0.9× 53 0.4× 193 1.8× 54 0.6× 30 961
Xiaojuan Hou China 19 511 1.4× 195 1.0× 140 1.1× 356 3.4× 13 0.1× 55 1.1k
Hong Yi China 20 489 1.3× 131 0.7× 28 0.2× 119 1.1× 13 0.1× 63 893

Countries citing papers authored by Hongjiang Xu

Since Specialization
Citations

This map shows the geographic impact of Hongjiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjiang Xu more than expected).

Fields of papers citing papers by Hongjiang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjiang Xu. The network helps show where Hongjiang Xu may publish in the future.

Co-authorship network of co-authors of Hongjiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjiang Xu. A scholar is included among the top collaborators of Hongjiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjiang Xu. Hongjiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ke, Zhihua Li, Junjun Zhang, et al.. (2025). Multifunctional green tea-loaded alginate/ polyvinyl alcohol aerogel pads: Fabrication, characterization, sustained release, and Salmon preservation. Innovative Food Science & Emerging Technologies. 107. 104301–104301. 1 indexed citations
2.
Ren, Jing, Ji-Nan Wang, Sheng Xu, et al.. (2025). Abstract 400: Preclinical development of TQB3019: A potent and selective oral BTK degrader leveraging the OAPD® platform to overcome acquired resistance mutations. Cancer Research. 85(8_Supplement_1). 400–400. 1 indexed citations
3.
Zhong, Zhaoyang, Lijuan Fu, Meihua Bao, et al.. (2024). Impact of Omicron Variant Infection on Female Fertility and Laboratory Outcomes: A Self‐Controlled Study. American Journal of Reproductive Immunology. 92(5). e70012–e70012. 3 indexed citations
4.
Wang, Bin, Weiwei Feng, Jinan Wang, et al.. (2021). Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton. Bioorganic & Medicinal Chemistry. 47. 116350–116350. 7 indexed citations
5.
Yang, Yan‐Zi, Zhihong Liu, Xiquan Zhang, et al.. (2020). Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs. European Journal of Pharmacology. 883. 173314–173314. 14 indexed citations
6.
Liu, Baomin, Hui Qin, Jie Wang, et al.. (2020). Discovery of a Silicon-Containing Pan-Genotype Hepatitis C Virus NS5A Inhibitor. Journal of Medicinal Chemistry. 63(10). 5312–5323. 27 indexed citations
7.
Zhang, Jinhua, et al.. (2020). Design, synthesis and biological evaluation of a novel N-aminoacyl derivative of amphotericin B methyl ester as an antifungal agent. European Journal of Medicinal Chemistry. 211. 113104–113104. 6 indexed citations
8.
Xu, Hongjiang, et al.. (2020). D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. Frontiers in Microbiology. 11. 563030–563030. 170 indexed citations
9.
10.
Li, Tushuai, Li Chen, Yan‐Zi Yang, et al.. (2019). Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1. Biochemical Pharmacology. 166. 139–152. 27 indexed citations
11.
Ma, Xueqin, et al.. (2019). Synthesis and biological evaluation of deuterated sofosbuvir analogs as HCV NS5B inhibitors with enhanced pharmacokinetic properties. Journal of Labelled Compounds and Radiopharmaceuticals. 62(5). 215–229. 6 indexed citations
12.
Ren, Jing, Wei Shi, Qinglin Wang, et al.. (2019). Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors. Bioorganic & Medicinal Chemistry. 28(2). 115236–115236. 18 indexed citations
13.
Liu, Baomin, Hui Qin, Yuan Cao, et al.. (2018). Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity. European Journal of Medicinal Chemistry. 148. 95–105. 8 indexed citations
14.
Zhao, Xiaojuan, Yan‐Zi Yang, Yan-Jing Zheng, et al.. (2018). Dataset on assessment of magnesium isoglycyrrhizinate injection for dairy diet and body weight in fructose-induced metabolic syndrome of rats. Data in Brief. 18. 69–75. 1 indexed citations
15.
Zeng, Shaogao, Yuwen He, Guicheng Zhang, et al.. (2017). Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluation. European Journal of Medicinal Chemistry. 141. 519–529. 14 indexed citations
16.
Zhao, Xiaojuan, Yan‐Zi Yang, Yan-Jing Zheng, et al.. (2017). Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder. European Journal of Pharmacology. 809. 141–150. 56 indexed citations
17.
Liu, Haiyan, et al.. (2016). Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study. Journal of Chromatography B. 1015-1016. 150–156. 12 indexed citations
18.
Zeng, Lili, Shaogao Zeng, Xin Lü, et al.. (2013). Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization. European Journal of Medicinal Chemistry. 68. 312–320. 18 indexed citations
19.
Zeng, Shaogao, Lili Zeng, Xin Lü, et al.. (2013). Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization. Bioorganic & Medicinal Chemistry. 21(7). 1749–1755. 14 indexed citations
20.
Peng, Li, Guicheng Zhang, Xiaobing Lan, et al.. (2010). The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. European Journal of Medicinal Chemistry. 46(1). 71–76. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Merlino Breakdown of academic impact, for papers by Yang Wan Breakdown of academic impact, for papers by Othman Al Musaimi Breakdown of academic impact, for papers by Linlin Chang Breakdown of academic impact, for papers by Seema Kumari Breakdown of academic impact, for papers by Franklin W. Okumu Breakdown of academic impact, for papers by Christina Lamers Breakdown of academic impact, for papers by Xiaojuan Hou Breakdown of academic impact, for papers by Hong Yi
Rankless by CCL
2026